Meetings: National Institute on Drug Abuse
Federal Register: June 25, 2010 (Volume 75, Number 122)
Notices
Page 36429-36430
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr25jn10-78
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
USC, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Medications Development for Substance Related
Disorders (R01).
Date: July 7-8, 2010.
Time: 9 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 20037.
Contact Person: Jose F. Ruiz, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd.,
Bethesda, MD 20892. 301-451-3086. ruizjf@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Medications Development for Cannabis-Related
Disorders (R01).
Date: July 8, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 20037.
Contact Person: Jose F. Ruiz, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Blvd.,
Bethesda, MD 20892. 301-451-3086. ruizjf@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA-K Conflicts SEP.
Date: July 13, 2010.
Time: 5:30 p.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard,
Bethesda, MD 20892-8401. 301-451-4530. elazarwe@nida.nih.gov.
Page 36430
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Deep Sequencing and Analysis of Pharmacogenomic
Regions.
Date: July 14, 2010.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minna Liang, PhD, Scientific Review
Administrator, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 220, MSC 8401, 6101 Executive Blvd., Bethesda, MD 20892. 301-435- 1432. liangm@nida.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: June 18, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
FR Doc. 2010-15490 Filed 6-24-10; 8:45 am
BILLING CODE 4140-01-P
